Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$3.87+0.15 (+4.03%)

Close on Nov 13, 2026Market cap $143.89MP/E –Yield –

Armata Pharmaceuticals statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 24, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $143.89M; $272.32M
Enterprise Value: $125.58M; $146.23M

Share statisticsIndustry

Shares Outstanding: 37M; 58M
Shares Change (YoY): 17.6%; 10.8%
Shares Change (QoQ): 0.13%; 0.50%
Shares Held by Institutions: 13.4%; 56.4%

Short sellingIndustry

Short Interest: 912,610; –
Short Interest Change: 1.44%; -0.80%
Short % of Shares Outstanding: 2.45%; 6.30%
Days to Cover: 9.78; 5.15

Stock price statisticsIndustry

52-Week High: $14.98; –
52-Week Low: $2.75; –
20-Day Moving Average: $3.39; –
50-Day Moving Average: $3.80; –
200-Day Moving Average: $6.87; –
Average True Range (14): $0.38; –
Price Change (1 Week): 10.3%; -1.15%
Price Change (1 Month): 25.2%; -4.87%
Price Change (3 Months): -13.6%; -21.0%
Price Change (6 Months): -51.9%; -20.6%
Price Change (YTD): -38.4%; -23.6%
Price Change (1 Year): -42.2%; -22.4%
Price Change (3 Years): 44.4%; -29.5%
Price Change (5 Years): 14.8%; -77.9%
Price Change (10 Years): -96.9%; -65.4%
Average Volume (10 Days): 65,901; –
Average Volume (20 Days): 76,579; –
Average Volume (90 Days): 173,624; –
Relative Volume: 0.16; 0.70
Relative Strength Index (14): 56.2; 43.4
Volatility (1 Year): 112.7%; 80.1%
Beta (5 Years): 0.86; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -127.2%; -40.6%

Financial positionIndustry

Current Ratio: 0.12; 3.30
Quick Ratio: 0.10; 2.39

EfficiencyIndustry

Profits Per Employee: -$1.81M; -$689.41K
Employee Count: 61; 74
WACC: 9.41%; 10.2%

Income statement (TTM)Industry

Operating Income: -$40.30M; -$21.37M
Net Income: -$110.65M; -$22.35M
EBITDA: -$40.30M; -$17.21M
EPS (Diluted): -$7.09; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $18.32M; $68.68M
Net Cash (Debt): $18.32M; $17.76M
Net Cash Per Share: $0.49; $0.80
Equity (Book Value): -$174.13M; $53.89M
Book Value Per Share: -$4.68; $1.50
Tangible Book Value: -$187.87M; $27.13M
Working Capital: -$164.18M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$26.64M; -$12.38M
Capital Expenditures: -$223.00K; -$1.00M
Free Cash Flow: -$26.86M; -$18.21M
FCF Per Share: -$0.72; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -76.9%; -21.8%
FCF Yield: -18.7%; -9.44%

Scores and fair valueIndustry

Altman Z-Score: -11.66; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	ARMP	S&P 500	Difference	ARMP per year	S&P 500 per year
1 month	+24.8%	-3.0%	+27.9 pts
3 months	-19.7%	-2.8%	−16.9 pts
Year to date	-38.4%	+11.5%	−49.9 pts
1 year	-39.3%	+13.5%	−52.8 pts
3 years	+57.3%	+77.7%	−20.4 pts	+16.3%	+21.1%
5 years	+14.8%	+72.6%	−57.8 pts	+2.8%	+11.5%
10 years	-97.2%	+308.2%	−405.3 pts	-30.0%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M ARMP shares were sold short on Oct 30, 2026, up 1.4% from the previous report. At recent volumes it would take 9.8 days to buy them back. Over the last 20 sessions, 72.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	912,610	+1.4%	93,354	9.8
Oct 15, 2026	899,639	-6.7%	105,326	8.5
Sep 30, 2026	964,187	+0.1%	160,890	6.0
Sep 15, 2026	963,383	+8.8%	583,217	1.6
Aug 31, 2026	885,291	+6.1%	101,940	8.7
Aug 14, 2026	834,737	-2.5%	130,045	6.4
Jul 31, 2026	856,363	+21.5%	171,953	5.0
Jul 15, 2026	704,657	+59.7%	154,722	4.5
Jun 30, 2026	441,157	+113.3%	302,873	1.5
Jun 15, 2026	206,873	-1.2%	53,575	3.9
May 29, 2026	209,363	-7.0%	84,420	2.5
May 15, 2026	225,033	-2.2%	77,207	2.9

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?